These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 34769250)

  • 21. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.
    Stern ME; Beuerman RW; Fox RI; Gao J; Mircheff AK; Pflugfelder SC
    Cornea; 1998 Nov; 17(6):584-9. PubMed ID: 9820935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The geoepidemiology of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos HM
    Autoimmun Rev; 2010 Mar; 9(5):A305-10. PubMed ID: 19903539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation.
    Pflugfelder SC; Tseng SC; Yoshino K; Monroy D; Felix C; Reis BL
    Ophthalmology; 1997 Feb; 104(2):223-35. PubMed ID: 9052626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
    Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.
    Chen YT; Lazarev S; Bahrami AF; Noble LB; Chen FY; Zhou D; Gallup M; Yadav M; McNamara NA
    Lab Invest; 2012 Apr; 92(4):556-70. PubMed ID: 22231738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.
    Reale M; D'Angelo C; Costantini E; Laus M; Moretti A; Croce A
    J Immunol Res; 2018; 2018():7510174. PubMed ID: 29977932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody.
    Hayashi Y; Ishimaru N; Arakaki R; Tsukumo S; Fukui H; Kishihara K; Shiota H; Yasutomo K; Hayashi Y
    Arthritis Rheum; 2004 Sep; 50(9):2903-10. PubMed ID: 15457459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
    Soyfoo MS; Chivasso C; Perret J; Delporte C
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
    Kang YS; Lee HS; Li Y; Choi W; Yoon KC
    Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic and viral factors in Sjögren's syndrome.
    Talal N
    Clin Exp Rheumatol; 1990; 8 Suppl 5():23-6. PubMed ID: 1700940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokines may prove useful in the treatment of Sjögrens syndrome (SS) dry eye.
    Talal N; Nakabayashi T; Letterio JJ; Kong L; Geiser AG; Dang H
    Adv Exp Med Biol; 1998; 438():953-8. PubMed ID: 9634993
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
    Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
    Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of intrinsic epithelial activation in the pathogenesis of Sjögren's syndrome.
    Manoussakis MN; Kapsogeorgou EK
    J Autoimmun; 2010 Nov; 35(3):219-24. PubMed ID: 20685080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjunctival cytologic features of primary Sjögren's syndrome.
    Pflugfelder SC; Huang AJ; Feuer W; Chuchovski PT; Pereira IC; Tseng SC
    Ophthalmology; 1990 Aug; 97(8):985-91. PubMed ID: 1698273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice.
    Yoon KC; De Paiva CS; Qi H; Chen Z; Farley WJ; Li DQ; Stern ME; Pflugfelder SC
    J Autoimmun; 2008 Jun; 30(4):212-21. PubMed ID: 17988834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca.
    de Paiva CS; Trujillo-Vargas CM; Schaefer L; Yu Z; Britton RA; Pflugfelder SC
    Front Immunol; 2021; 12():702755. PubMed ID: 34349764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune epithelitis in primary Sjögren's syndrome.
    Desvaux E; Pers JO
    Joint Bone Spine; 2023 Mar; 90(2):105479. PubMed ID: 36336290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease.
    Mostafa S; Seamon V; Azzarolo AM
    Exp Eye Res; 2012 Mar; 96(1):88-97. PubMed ID: 22227485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sjögren's syndrome.
    Mavragani CP; Moutsopoulos HM
    Annu Rev Pathol; 2014; 9():273-85. PubMed ID: 24050623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.